Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Ringworm Disease: Market Insight Epidemiology , Forecast , Prevention, Redefining Market Entry Strategies, & Disrupting Competitive intelligences by Disease Landscape Insights


News provided by

Disease Landscape Insights

Sep 13, 2023, 10:10 ET

Share this article

Share toX

Share this article

Share toX

Disease Landscape Insights equips healthcare pioneers with the tools to combat ringworm early stages, providing in-depth diagnostic, treatment, and market insights. Although ringworm is a common fungal infection, it can be particularly troublesome due to its ability to affect various parts of the body. DLI's Healthcare Consulting Services play a vital role in streamlining the process of conducting Clinical Trial Assessment for new ringworm treatments and medications, contributing to aspects such as patient recruitment strategies and regulatory consulting.

LONDON, Sept. 13, 2023 /PRNewswire/ -- Ringworm Disease, despite its misleading name, is a common fungal infection that affects the skin, nails, and occasionally the scalp. To effectively combat this troublesome condition, it's essential to understand how to diagnose, treat, and manage it. In this article, we will explore the various diagnostic and treatment options available for ringworm in cats and how Disease Landscape Insights, a healthcare and pharma consulting services company, can assist at every step.

Diagnostic Analysis

Diagnosing ringworm accurately is the crucial first step toward effective 3 day ringworm treatment. Traditional diagnostic techniques are the backbone of this process.

Conventional Diagnostic Techniques

Healthcare providers often rely on their expertise to visually inspect and diagnose ringworm based on characteristic symptoms. These symptoms include a red, circular rash with raised edges and itching. However, visual diagnosis alone may not provide information about the specific type of fungus causing the infection or its severity.

Solutions for Dermatophytosis

Dermatophytosis, the medical term for ring worms, can be challenging to identify definitively without additional diagnostic tools.

Microscopic Examination Dependent Techniques

Microscopic examination involves collecting a sample from the affected area and studying it under a microscope. This method allows healthcare professionals to visualize fungal elements such as hyphae or spores. While it aids in confirming the presence of fungus, it may not always provide information about the precise type or severity of the infection.

Price and Market Access

Modified Rapid Culturing Techniques

To gain a more detailed understanding of the fungus responsible for the infection, modified rapid culturing techniques are employed. A sample is taken from the affected area and cultured in a controlled environment to encourage fungal growth. This approach helps in identifying the specific species of the fungus and assessing its severity.

Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry (MALDI-TOF) Based Techniques

In cases where traditional methods fall short, advanced techniques like MALDI-TOF mass spectrometry come into play. This cutting-edge technology analyzes the protein profiles of fungal samples, allowing for precise identification of the fungus responsible. It's a game-changer in diagnosing and understanding ringworm infections.

Molecular Diagnostic Techniques

Molecular diagnostic techniques involve studying the genetic material of the fungus. By analyzing the DNA, healthcare professionals can pinpoint the exact species of the fungus and gain valuable insights into its virulence and resistance patterns.

Therapeutic Analysis

Once the diagnosis is confirmed, the next step is ringworm treatment at home. Effective therapeutic analysis is crucial to ensure a swift recovery.

Over-the-Counter Antifungals

For mild cases of ringworm on leg, over-the-counter antifungal creams and ointments are often sufficient. They work by targeting and eradicating the fungus, alleviating symptoms and promoting healing.

In more severe or persistent cases, healthcare providers may prescribe stronger antifungal medications. These can be administered orally or topically, depending on the location and extent of the infection. DLI helps in Product Portfolio Analysis further narrowing down the process.

Learn More About the FDA NDA & BLA Approval (NME) Drugs for Psoriasis Disease @ https://www.diseaselandscape.com/requestsample/postid/67

The Market Landscape for Ringworm Disease

Unveiling Key Players and Innovations in Ringworm Treatment

The ringworm disease market hosts a variety of global players offering effective antifungal medications. Additionally, promising innovations are in development that could revolutionize the market. For example, Blueberry Therapeutics is currently advancing Terbinafine Hydrochloride in Phase 2, a potentially game-changing therapy for ringworm. This breakthrough holds promise for highly efficient ringworm treatment for humans, paving the way for enhanced patient care.

Furthermore, Viamet Pharmaceuticals is conducting phase 2 clinical trials for osteoseconzole to treat onychomycosis. The progress observed in these trials reflects the industry's commitment to improving patient outcomes and underscores the potential for innovation in this field.

According to the World Health Organization (WHO), Dermatophytosis affects 25% of the global population, with 30 to 70% of individuals experiencing asymptomatic conditions. Approximately 20-25% of people worldwide are affected by ringworm on people. This high prevalence is attributed to increased migration, tourism, and interactions with ringworm-infected animals.

Clinical Trial Assessment

In some instances, conventional treatments may not yield the desired results. This is where clinical trials come into play.

Clinical Trial Assessment

Clinical trials are research studies designed to test new treatments or therapies for various medical conditions, including ringworm rash. Participating in a clinical trial can provide access to cutting-edge treatments and contribute to advancing medical knowledge.

Unlock the Benefits Today! Get Started Now and Elevate Your Experience @
https://www.diseaselandscape.com/checkout?report_id=67

The ongoing ringworm clinical trials are:

PHASE 1 (Human Pharmacology)

PHASE 2 (Therapeutic Exploratory Trail)

PHASE 3 (Therapeutic Confirmatory Trial)

PHASE 4 (Post Marketing Surveillance)

An Open Label, Parallel Group Comparison Study to Evaluate the Safety Tolerability and Pharmacokinetics of UHE-103 Cream Versus Naftin Cream in Subjects with Tinea Cruris and/or Tinea Pedis Under Maximal Use Conditions

An Open-Label Phase 2a Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Hallux Terbinafine Subungual Gel Administered to the Toenail Bed of Patients with Distal-Lateral Subungual Onychomycosis

A Multi-center, Double-blind, Randomized, Vehicle-controlled Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)


Pilot Study to Determine the Safety and Efficacy of Regimen Frequencies Using the Swift Microwave Device for Mild to Moderate Toenail Onychomycosis Caused by Dermatophytes

Pilot Study to Determine the Safety and Efficacy of Regimen Frequencies Using the Swift Microwave Device for Mild to Moderate Toenail Onychomycosis Caused by Dermatophytes



A Phase 1, First in Human, Randomized, Double-Blind, Placebo-Controlled Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ATB1651 in Adults with Mild to Moderate Onychomycosis




DLI: Your Partner in Healthcare and Pharma

DLI, a trusted healthcare consulting and pharma consulting company, plays a pivotal role in supporting healthcare providers and pharmaceutical companies in the battle against ringworm stages. Here's how DLI can assist:

Advanced Diagnostic Solutions: DLI offers access to state-of-the-art Disease insights and Drug Insights, including MALDI-TOF mass spectrometry and molecular diagnostic techniques. These tools aid in accurate diagnosis and better understanding of ringworm on foot infections.

Treatment Strategy: DLI with its Ringworm Disease Overview collaborates with healthcare providers to develop tailored treatment strategies. With a deep understanding of the latest therapeutic options, DLI ensures patients receive the most effective treatments available.

Clinical Trial Support: DLI facilitates clinical trial assessments and Drug Development, connecting patients with opportunities to participate in studies exploring innovative ringworm treatments for cats. Their expertise streamlines the process, ensuring patient safety and compliance.

Discover More About Pricing and Reimbursement, Epidemiology Study, and Healthcare @ https://www.diseaselandscape.com/downloadsample/postid/67

Last Words

Ringworm may be a common fungal infection, but its diagnosis and treatment require precision and expertise. With DLI as your Pricing and Market Access partner, you can access advanced diagnostic tools, personalized treatment plans, and the opportunity to contribute to cutting-edge research. Together, we can better understand, treat, and ultimately conquer ringworm on leg.

Search more about Infectious Diseases

Related Reports: 

Exploring Solid Tumor Epidemiology: Studies, Market Size, and Forecasts 

Global Landscape of Lung Cancer Services: Insights and Trends 

Pneumonia Demystified: Symptoms, Causes, and Prevention Strategies 

Demodex Blepharitis: How to Achieve Eye Health and Eliminate Demodex 

Understanding Lupus: Navigating the Complex Autoimmune Disorder 

Comprehensive Guide to Ringworm: Symptoms, Causes, and Effective Treatment 

Alzheimer's Disease Uncovered: Symptoms, Diagnosis, and Treatment Insights 

Parkinson's Disease Explored: Symptoms, Causes, and Treatment Breakthroughs 

Comprehensive Guide to Diverticulitis: Symptoms, Causes, and Solutions 

Revolutionizing Healthcare: Harnessing AI-Powered Predictive Analytics 

The Role of AI in Medical Imaging: Revolutionizing Healthcare 

AI-Driven Personalized Medicine: Ethics and Responsibility 

Ethical Considerations in AI Healthcare Solutions: Balancing Innovation and Responsibility 

Advancements in Natural Language Processing (NLP) for Healthcare 

Exploring the Leading Causes of Cancer Deaths: Identifying Deadly Contributors 

Inpefa by Lexicon Pharmaceuticals: A Breakthrough in Medical Innovation 

Empowering Hope: Paxlovid - A COVID-19 Breakthrough Treatment 

Posluma: Advancing Prostate Cancer Imaging in Targeted Oncology 

Xacduro by Innoviva Specialty Therapeutics: Empowering Bacterial Pneumonia Treatment

About Disease Landscape: 

Disease Landscape, a pioneering company specializing in Disease Intelligence, Pricing, and Market Access. Utilizing the power of data analytics, Disease Landscape Insights is dedicated to healthcare sector with invaluable, finely crafted insights and recommendations regarding global pricing and market access strategies. As a specialized firm, we are committed to delivering unparalleled insights into pricing and market access, custom-tailored to the healthcare and pharmaceutical industries. Our data-driven solutions and cutting-edge technology position us as your trustworthy partner, offering swift, adaptable, and evidence-based alternatives to traditional market access and pricing research methods. 

Our core competencies encompass Market Research Services, Consulting Services, Global Pricing and Market Access, Epidemiology Studies, as well as Product Portfolio and Pipeline Services. Our expertise lies in furnishing comprehensive data intelligence throughout every phase of drug and device research. 

Contact Us:
Disease Landscape Insights LLP
6th Floor, Sr No.207, Office A H 6070 Phase 1
Solitaire Business Hub, Viman Nagar
Pune, Maharashtra, 411014
Email: [email protected]   
Email: [email protected]
Corporate Sales: +44-2038074155 
Asia Office: +917447409162
Blog: https://www.diseaselandscape.com/blogs
Case Study: https://www.diseaselandscape.com/casestudies  
Pharma consulting Services

Follow Us: LinkedIn | Twitter | Facebook 

SOURCE Disease Landscape Insights

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.